Reported infections after human tissue transplantation before and after new food and drug administration (FDA) regulations, United States, 2001 through June, 2010

Cell and Tissue Banking

Volumn 13, Issue 2, 2012, Pages 259-267

  Mallick, Tarun K ^a   Mosquera, Alexis ^a   Zinderman, Craig E ^a   Martin, Laura St ^a   Wise, Robert P ^a  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

Author keywords

Allografts; Infections; Surveillance; Tissue

Indexed keywords

ALLOTRANSPLANTATION; ARTICLE; DEATH; FOOD AND DRUG ADMINISTRATION; HOSPITALIZATION; HUMAN; INFECTION; LEGAL ASPECT; MICROBIOLOGY; RESEARCH; SOCIAL CONTROL; STATISTICS; TIME; TRANSPLANTATION; UNITED STATES; VIROLOGY;

DEATH; HOSPITALIZATION; HUMANS; INFECTION; RESEARCH REPORT; SOCIAL CONTROL, FORMAL; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS; TRANSPLANTS; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 84861531473     PISSN: 13899333     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10561-011-9253-5     Document Type: Article

References (25)

1. American Association of Tissue Banks (2010) 2007 American association of tissue banks (AATB) annual survey of accredited tissue banks in the United States. McLean, VA
2. Blossom DB, Maddox RA, Beavers SF, Church KA, Thoroughman DA, Schonberger LB, Belay ED (2007) A case of Creutzfeldt-Jakob disease associated with a dura mater graft in the United States. Infect Control Hosp Epidemiol 28 (12): 1396-1397 (Pubitemid 351412090)
3. Cartwright EJ, Prabhu RM, Zinderman CE, Schobert WE, Jensen B, Noble-Wang J, Church K, Welsh C, Kuehnert M, Burke TL, Srinivasan A, Food and Drug Administration Tissue Safety Team Investigators (2010) Transmission of Elizabethkingia meningoseptica (formerly Chryseobacterium meningosepticum) to tissue-allograft recipients: a report of two cases. J Bone Joint Surg Am 92 (6): 1501-1506
4. Centers for Disease Control (1988) Transmission of HIV through bone transplantation: case report and public health recommendations. MMWR Morb Mortal Wkly Rep 37 (39): 597-599 (http: //www.cdc.gov/mmwr/preview/mmwrhtml/00001284. htm, accessed October 28, 2010)
5. Centers for Disease Control, Prevention (2001) Septic arthritis following anterior cruciate ligament reconstruction using tendon allografts-Florida, Louisiana, 2001. MMWR Morb Mortal Wkly Rep 50 (48): 1081-1083
6. Centers for Disease Control, Prevention (2002) Update: allograft-associated bacterial infections-United States, 2002. MMWR Morb Mortal Wkly Rep 51(10):207-210
7. Centers for Disease Control and Prevention (2003a) Invasive Streptococcus pyogenes after allograft implantation-Colorado, 2003. MMWR Morb Mortal Wkly Rep 52 (48): 1174-1176
8. Centers for Disease Control and Prevention (2003b) Hepatitis C virus transmission from an antibody-negative organ and tissue donor-United States, 2000-2002. MMWR Morb Mortal Wkly Rep 52 (13): 273-276
9. Centers for Disease Control and Prevention, Food and Drug Administration, and Health Resources and Services Administration, Department of health and Human services (2005) Workshop on preventing organ and tissue allografttransmitted infection: priorities for public health intervention. 2005 June 2-3. http: //www.cdc.gov/ncidod/dhqp/pdf/bbp/organ-tissueWorkshop-June2005. pdf Accessed 2011 March 15
10. Centers for Disease Control, Prevention (2006) Brief report: investigation into recalled human tissue for transplantation-United States, 2005-2006. MMWR Morb Mortal Wkly Rep 55(20):564-566
11. Chen RT, Rastogi SC, Mullen JR, Hayes S, Cochi SL, Donlon JA, Wassilak SG (1994) The Vaccine Adverse Event Reporting System (VAERS). Vaccine 12: 542-550
12. Food and Drug Administration (2002) Public health web notification: Human tissue processed by Cryolife, Inc. (http: //www.fda.gov/MedicalDevices/Safety/ Alertsand Notices/PublicHealthNotifications/UCM064529, accessed October 28, 2010)
13. Food and Drug Administration (2005) Guidance for industry: MedWatch Form FDA 3500A: Mandatory Reporting of adverse reactions related to human cells, tissues, and cellular and tissue-based products (HCT/Ps) (http: //www. fda.gov/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/ Guidances/Tissue/ucm074000. htm, accessed October 28, 2010)
14. Food and Drug Administration (2009) MedSun: Medical product safety network (http: //www.fda.gov/Medical Devices/Safety/ MedSunMedicalProductSafetyNetwork/default.htm, accessed October 28, 2010)
15. Food and Drug Administration (2010) 21 CFR 1270.150, Current good tissue practice requirements (http: //www.fda.gov/BiologicsBloodVaccines/ GuidanceComplianceRegulatoryInformation/ActsRulesRegulations/ TissueProposedFinalRules/default.htm)
16. Joint Commission (2010) Standards TS.03.01.01-TS.03.03.01 (http: //www.lpitsolutions.com/support/complianceresources.aspx, accessed March 17 2011
17. Joyce M, Strong DM, Brubaker S, Mroz TE (2010) Tracking and tracing of allograft tissue based on a common universal donor number are lacking: progress and obstacles on atransplantation transmission sentinel network (TTSN). US Musculoskeletal Review 2010; 5: 36-8
18. Kainer MA, Linden JV, Whaley DN, Holmes HT, Jarvis WR, Jernigan DB, Archibald LK (2004) Clostridium infections associated with musculoskeletal- tissue allografts. N Engl J Med 350 (25): 2564-2571 (Pubitemid 38758543)
19. Lang CJ, Heckmann JG, Neundörfer B (1998) Creutzfeldt-Jakob disease via dural and corneal transplants. J Neurol Sci 160 (2): 128-139 (Pubitemid 28522537)
20. Maddox RA, Belay ED, Curns AT, Zou WQ, Nowicki S, Lembach RG, Geschwind MD, Haman A, Shinozaki N, Nakamura Y, Borer MJ, Schonberger LB (2008) Creutzfeldt-Jakob disease in recipients of corneal transplants. Cornea 27 (7): 851-854
21. Public Health Service Biovigilance Task Group (2009) Biovigilance in the United States: efforts to bridge a critical gap in patient safety and donor health. (http: //www.hhs.gov/ash/bloodsafety/biovigilance/ash-to-acbsa-oct-2009. pdf.pdf, accessed December 15, 2010)
22. Strom BL, Tugwell P (1990) Pharmacoepidemiology: current status, prospects, and problems. Ann Intern Med 113 (3): 179-181 (Pubitemid 20242292)
23. Strong DM, Seem D, Taylor G, Parker J, Stewart D, Kuehnert MJ (2010) Development of a transplantation transmission sentinel network to improve safety and traceability of organ and tissues. Cell Tissue Bank, 2010 Jul 21
24. Vangsness CT Jr, Wagner PP, Moore TM, Roberts MR (2006) Overview of safety issues concerning the preparation and processing of soft-tissue allografts. Arthroscopy 22 (12): 1351-1358 (Pubitemid 44854433)
25. Wang S, Zinderman C, Wise R, Braun M (2007) Infections and human tissue transplants: review of FDA MedWatch reports 2001-2004. Cell Tissue Bank 8: 211-219 (Pubitemid 47202290)